← Scroll for more →
Alumis Inc. (ALMS)
Pharmaceutical Preparations
Latest Price
$7.39
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
3.54
P/B Ratio
2.09
Institutional Ownership
93.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| AyurMaya Capital Management Company, LP | 15.14M | $426.0M | 11.98% | -- | 2026-06-30 |
| BlackRock, Inc. | 8.22M | $231.0M | 6.50% | +1.05M | 2026-06-30 |
| FMR LLC | 6.77M | $190.0M | 5.36% | +5.80M | 2026-06-30 |
| Deep Track Capital, LP | 6.35M | $178.0M | 5.02% | -424.0K | 2026-06-30 |
| Samsara Biocapital, LLC | 6.35M | $178.0M | 5.02% | -- | 2026-06-30 |
| Foresite Capital Management V, LLC | 5.90M | $165.0M | 4.67% | -- | 2026-06-30 |
| Price T Rowe Associates Inc | 5.20M | $146.0M | 4.11% | +1.91M | 2026-06-30 |
| venBio Partners LLC | 4.53M | $127.0M | 3.58% | -- | 2026-06-30 |
| Foresite Capital Management VI LLC | 4.25M | $119.0M | 3.36% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 4.22M | $118.0M | 3.34% | +183.4K | 2026-06-30 |